Cover Image
市場調查報告書

中國的Budesonide市場分析

Investigation Report on China Budesonide Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 296859
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的Budesonide市場分析 Investigation Report on China Budesonide Market, 2010-2019
出版日期: 2015年06月11日 內容資訊: 英文 30 Pages
簡介

Budesonide的吸入停止(商標名「Pulmicort Respules」)由Astra Zeneca開發,作為氣喘的治療藥2000年獲得美國FDA(食品藥物管理局)銷售認證。中國在2001年也獲得認證。在中國國內現在呼吸系統疾病的患者約有3億人,其中5,000萬人主訴咳嗽的症狀,一年增加4%的比例。還有1,500∼2,000萬人患氣喘病。因此中國的Budesonide市場年複合成長率(CAGR)(2005∼2014年)達到29%,依然有莫大需求。

本報告提供中國的Budesonide市場相關分析、中國國內的產量及醫院用銷售額、價格趨勢(過去5年份)、各企業、各投藥形態的市場佔有率、主要製造商簡介、未來性的市場趨勢預測(今後5年份)等調查,並將其結果為您概述為以下內容。

第1章 Budesonide的相關概念

  • 症狀
  • 全球市場的銷售情形

第2章 中國的Budesonide市場概要

  • 專利現況
  • 主要製造商
  • 市場規模

第3章 Budesonide的銷售額分析

  • 銷售額
    • 總銷售額
    • 各地區
  • 銷售量
    • 整體銷售量
    • 各地區

第4章 主要廠商的市場佔有率分析

  • 市場佔有率(以金額為準)
  • 市場佔有率(以數量為準)

第5章 各劑型的市場規模分析

  • 各劑型的市場佔有率(以金額為準)
  • 各劑型的市場佔有率(以數量為準)

第6章 Budesonide的醫院用標準價格(各企業)

  • SYNMOSA BIOPHARMA CORPORATION (TW)
  • WELLCOME AUSTRALIA LTD.(AU)
  • Shanghai Sine Pharmaceutical Co Ltd
  • Orion Corporation
  • Astra AB (Sweden)
  • Lunan Better Pharmaceutical Co., Ltd

第7章 主要製造商分析

  • Shanghai Sine Pharmaceutical Co Ltd
  • Lunan Better Pharmaceutical Co., Ltd.
  • Astra AB (Sweden)
  • WELLCOME AUSTRALIA LTD.(AU)
  • AstraZeneca Australia
  • AstraZeneca plc.
  • Lunan Better Pharmaceutical Co., Ltd.
  • SYNMOSA BIOPHARMA CORPORATION

第8章 中國的Budesonide市場未來展望

  • 市場規模的預測
  • 市場競爭的預測

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1506210

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma, more so in industrialized countries and regions where tobacco consumption is high. 5% of adults and 20% of children there have been attacked by this disease and many of them come down with bronchial asthma induced by chronic cough.

Nearly 300 million people in China contract respiratory ailments, among which over 50 million suffer from cough with an annual growth rate of 4% and 15-20 million asthma.

Budesonide, an adrenocortical hormone, was developed by Astrazeneca in the 1990s. It is mainly used for the treatment of non-glucocorticoid dependent or glucocorticoid-dependent bronchial asthma and chronic obstructive pulmonary disease (COPD). In Jun. 1997, budesonide aerosol got FDA's approval. In recent years, with the steady growth of global demand, budesonide has occupied an important position in the TOP10 respiratory drugs.

In 1994, China approved the import of budesonide for clinical purposes. After being marketed by Astra (Wuxi) in China in 1995, budesonide develops fast with annual sales rising from CNY 60 million in 2005 to CNY 595 million in 2014 and CAGR reaching up to 29% during the period of 2005-2014. Budesonide enjoys a vast demand in China. Currently, budesonide in the Chinese market mainly come from the following companies: Lunan Better Pharmaceutical Co., Ltd, Orion Corporation (Finland), WELLCOME AUSTRALIA LTD.(AU), SYNMOSA BIOPHARMA CORPORATION (TW) and Astra AB (Sweden). While they all take up certain shares in the market, WELLCOME AUSTRALIA LTD.(AU) has the largest market share of 88% with sales value reaching up to CNY 524 million in 2014.

The market size of budesonide in China is expected to keep growing in the next few years.

Readers can get at least the following information from this report:

  • market size of budesonide in China
  • market share of manufacturers of budesonide in China
  • price of budesonide in Chinese market
  • major manufacturers of budesonide in Chinese market
  • market outlook of budesonide in China

The author suggests the following groups of people purchase this report:

  • manufacturers of cortin drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Budesonide

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Budesonide in China

  • 2.1. Patent and Approval Status of Budesonide in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Budesonide in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Budesonide in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Budesonide in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Budesonide in Chinese Hospitals in 2014

  • 6.1. SYNMOSA BIOPHARMA CORPORATION (TW) (Trade Name: Rhinocort)
  • 6.2. WELLCOME AUSTRALIA LTD.(AU)
  • 6.2. WELLCOME AUSTRALIA LTD.(AU)
  • 6.3. Shanghai Sine Pharmaceutical Co Ltd (Trade Name: Bao Yi Su)
  • 6.4. Orion Corporation (Finland) (Trade Name: Antrex)
  • 6.5. Astra AB (Sweden) (Trade Name: Pulmicort)
  • 6.6. Lunan Better Pharmaceutical Co., Ltd (Trade Name: Ji Shu)

7. Major Manufacturers of Budesonide in Chinese Market, 2010-2014

  • 7.1. Shanghai Sine Pharmaceutical Co Ltd
  • 7.2. Lunan Better Pharmaceutical Co., Ltd
  • 7.3. Astra AB (Sweden)
  • 7.4. WELLCOME AUSTRALIA LTD
  • 7.4. WELLCOME AUSTRALIA LTD
  • 7.5. SYNMOSA BIOPHARMA CORPORATION
  • 7.5. SYNMOSA BIOPHARMA CORPORATION

8. Market Outlook of Budesonide in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Budesonide in China
  • Chart Approval Information of Budesonide in China
  • Chart Sales Status of Budesonide in China
  • Chart Sales Value of Budesonide in China, 2010-2014
  • Chart Sales Value of Budesonide in Some Regions in China, 2010-2014
  • Chart Sales Volume of Budesonide in China, 2010-2014
  • Chart Market Share of TOP4 Manufacturers of Budesonide for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Made by WELLCOME AUSTRALIA LTD.(AU) in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Made by Astra (Sweden) in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Made by Lunan Better in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Made by SYNMOSA(TW) in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Nasal Spray in China, 2010-2014
  • Chart Sales Value and Market Share of Budesonide Aerosol in China, 2010-2014
  • Chart Price of Budesonide Made by SYNMOSA BIOPHARMA CORPORATION (TW) in Some Chinese Cities in 2014
  • Chart Price of Budesonide Made by WELLCOME AUSTRALIA LTD.(AU) in Some Chinese Cities in 2014
  • Chart Price of Budesonide Made by Sine in Some Chinese Cities in 2014
  • Chart Price of Budesonide Made by Orion Corporation (Finland) in Some Chinese Cities in 2014
  • Chart Price of Budesonide Made by Astra AB (Sweden) in Some Chinese Cities in 2014
  • Chart Price of Budesonide Made by Lunan Better Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top